Clinical Trials

NCT05185947 | COMPLETED | PHASE2
21 participants

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-25
Start Date:
2022-10-13
Completion:
2025-01-27
Conditions
  • Gynecologic Cancer
  • Gynecologic Neoplasms
  • Peritoneal Carcinomatosis
  • Peritoneal Neoplasms
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Colorectal Cancer
  • Colorectal Neoplasms
  • Appendiceal Cancer
  • Appendiceal Neoplasms
  • Cholangiocarcinoma
  • Breast Cancer
Interventions
  • DRUG
  • DIAGNOSTIC_TEST
  • PROCEDURE
NCT05183698 | TERMINATED
11 participants

Point-spectroscopy Trial

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-25
Start Date:
2022-02-24
Completion:
2022-12-01
Conditions
  • Wound
  • Wound of Skin
No Results Yet
NCT05050162 | SUSPENDED | PHASE2/PHASE3
1714 participants

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-25
Start Date:
2022-02-01
Completion:
2027-02-09
Conditions
  • Advanced Head and Neck Squamous Cell Carcinoma
  • Advanced Hypopharyngeal Squamous Cell Carcinoma
  • Advanced Laryngeal Squamous Cell Carcinoma
  • Advanced Oropharyngeal Squamous Cell Carcinoma
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • OTHER
  • RADIATION
No Results Yet
NCT04869683 | RECRUITING | NA
150 participants

Biocollection in MyeloDysplastic Syndrome (P-MDS)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-25
Start Date:
2022-10-19
Completion:
2032-10-19
Conditions
  • Myelodysplastic Syndromes
  • Myelodysplastic Anemia
  • Myelodysplastic Syndrome With Isolated Del(5Q)
  • Myelodysplastic Syndrome With Ring Sideroblasts
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • Chromosome Abnormality
Interventions
  • OTHER
No Results Yet
NCT04862650 | ACTIVE_NOT_RECRUITING | PHASE2
46 participants

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-25
Start Date:
2021-11-30
Completion:
2026-06-12
Conditions
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Hypopharyngeal Squamous Cell Carcinoma
  • Metastatic Laryngeal Squamous Cell Carcinoma
  • Metastatic Oral Cavity Squamous Cell Carcinoma
  • Metastatic Oropharyngeal Squamous Cell Carcinoma
  • Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Unknown Primary
  • Stage IV Hypopharyngeal Carcinoma AJCC v8
  • Stage IV Laryngeal Cancer AJCC v8
  • Stage IV Lip and Oral Cavity Cancer AJCC v8
  • Stage IVA Hypopharyngeal Carcinoma AJCC v8
  • Stage IVA Laryngeal Cancer AJCC v8
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8
  • Stage IVB Hypopharyngeal Carcinoma AJCC v8
  • Stage IVB Laryngeal Cancer AJCC v8
  • Stage IVB Lip and Oral Cavity Cancer AJCC v8
  • Stage IVC Hypopharyngeal Carcinoma AJCC v8
  • Stage IVC Laryngeal Cancer AJCC v8
  • Stage IVC Lip and Oral Cavity Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04820946 | TERMINATED
4 participants

Evolution of DMDD Children and Adolescent

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-25
Start Date:
2022-11-16
Completion:
2026-03-09
Conditions
  • Disruptive Mood Dysregulation Disorder
  • Prognosis Factors
  • Suicidal Behaviors
  • Actigraphy
No Results Yet
NCT04792931 | RECRUITING | NA
60 participants

Adult Autoimmune Myopathies (MAIA)

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-25
Start Date:
2022-05-20
Completion:
2030-05-20
Conditions
  • Idiopathic Inflammatory Myopathies
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page